WeVote
Log In

Bill

Bill

HR 9830

Lawful Hemp Protection Act

119th Congress Introduced by Andy Barr and 3 co-sponsors

HR 9830 preserves lawful hemp commerce while curbing high-THC synthetic intoxicants to protect consumers and public health.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 9830

Overview

House Resolution 9830 (HR 9830) aims to preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants. Introduced in the 119th Congress and currently referred to several committees, the bill seeks to balance support for legitimate hemp products with safeguards against synthetic cannabinoids and related products that could be misused or pose public health risks.

Purpose and intent

  • Preserve lawful hemp commerce: Support ongoing activities involving hemp-derived products that are compliant with federal definitions and regulations.
  • Protect consumers from high-THC synthetic intoxicants: Provide measures to curb the production, sale, and distribution of synthetic cannabinoids and other high-THC substances marketed as or resembling hemp or cannabis products.
  • Promote public health and safety: Address consumer protection concerns related to mislabeled, adulterated, or dangerously potent products in the hemp and cannabis ecosystem.

Key provisions and changes (anticipated focus based on title and typical framework)

Note: The bill’s detailed text would specify exact mechanisms. Based on the title and common legislative approaches, expected areas include:

  • Regulatory alignment for hemp products:

    • Clarifications on what constitutes lawful hemp and hemp-derived products under federal law.
    • Confirmation of permissible levels of delta-9 THC in hemp, consistent with the federal threshold (commonly up to 0.3% by dry weight, though this specific bill’s text would dictate exact parameters if different).
    • Standards for labeling, testing, and verification of hemp products to ensure compliance and traceability.

  • Consumer protection from synthetic intoxicants:

    • Prohibitions or tighter restrictions on sale of synthetic cannabinoids and other intoxicants marketed as hemp or cannabis products.
    • Enhanced enforcement authorities to identify and remove high-THC synthetic products from the market.
    • Potential penalties for manufacturers, distributors, or retailers selling prohibited synthetic compounds.

  • Authority and oversight:

    • References to coordination among federal agencies (e.g., agencies related to commerce, health, agriculture, transportation) to implement and enforce provisions.
    • Possible creation or designation of enforcement programs, funding, or grant authorities to support compliance and public health initiatives.

  • Impact on retailers and producers:

    • Rules affecting cultivation, processing, packaging, and distribution of hemp-derived products.
    • Compliance timelines or phased-in requirements for businesses to adjust to new standards.

Who would be affected

  • Hemp growers, processors, and product manufacturers.
  • Retailers and distributors of hemp-derived goods (including consumer products like foods, supplements, and topicals that fall within hemp commerce definitions).
  • Consumers of hemp-derived products, who could benefit from enhanced labeling and safety protections.
  • Federal and state regulators and law enforcement agencies tasked with enforcing hemp and synthetic cannabinoid restrictions.
  • Public health entities monitoring the impact of synthetic intoxicants.

Procedural and timeline aspects

  • Introduction: The bill was introduced in the House and has sponsors including Angie Craig and Andy Barr.
  • Referral: Referred to the Committee on Ways and Means, with additional referrals to the Energy and Commerce, Agriculture, and Transportation and Infrastructure committees for provisions within their jurisdiction.
  • Next steps: The committees will consider provisions within their jurisdiction; potential committee reports or amendments could advance the bill to the floor for debate and vote.
  • Timeline specifics: The summary does not provide a firm passage date; typical timelines depend on committee action, scheduling, and floor consideration.

Potential impacts and considerations

  • Clarity and consistency: The bill could reduce ambiguity around what qualifies as lawful hemp vs. illegal or high-THC products.
  • Market effects: Businesses may need to alter product formulations, labeling, and testing regimes to remain compliant.
  • Public health: Stronger protections against high-THC synthetic intoxicants could reduce consumer exposure to dangerous products.
  • Interagency coordination: Effective implementation would require clear guidelines across multiple federal agencies.

If you would like, I can tailor this summary further once the full text is available, including specific sections, definitions, penalties, and funding provisions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.